10-Q: Quarterly report
Q1 2024 Tenon Medical Inc Earnings Call
Earnings Call Summary | Tenon Medical(TNON.US) Q1 2024 Earnings Conference
The following is a summary of the Tenon Medical, Inc. (TNON) Q1 2024 Earnings Call Transcript:Financial Performance:Tenon Medical reported Q1 2024 revenue of $719,000, a 66% increase from the same per
Tenon Medical, Inc. (TNON) Q1 2024 Earnings Call Transcript
Tenon Medical, Inc. (TNON) Q1 2024 Earnings Call Transcript
Tenon Medical Inc (TNON) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
Express News | Tenon Medical Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Sales Results
Tenon Medical Q1 2024 GAAP EPS $(1.25) Beats $(1.34) Estimate, Sales $719.00K Miss $783.00K Estimate
Tenon Medical (NASDAQ:TNON) reported quarterly losses of $(1.25) per share which beat the analyst consensus estimate of $(1.34) by 6.72 percent. This is a 70.93 percent increase over losses of $(4.30)
Express News | Tenon Medical Q1 Net Income USD -3.576 Million
Express News | Tenon Medical Q1 Operating Expenses USD 3.976 Million
Express News | Tenon Medical Q1 Revenue USD 719 Thousand
Tenon Medical Reports First Quarter 2024 Financial Results
~ Revenue Increased 66% Year-Over-Year ~~ Surgical Procedures Increased 42% Year-Over-Year ~~ Gross Margin Stabilized at 65% Sequentially ~~ Catamaran SI Joint Fusion System Received Positive Fusion R
Express News | Tenon Medical Inc Files For Resale Of Up To 5M Common Shares By The Selling Stockholder
Express News | Tenon Medical Inc Files for Resale of up to 5.0 Mln Common Shares by the Selling Stockholder - SEC Filing
Tenon Medical, Inc. Announces Timing of First Quarter 2024 Financial Results
LOS GATOS, CA / ACCESSWIRE / April 30, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint)
Tenon Medical Is Maintained at Speculative Buy by Benchmark
Tenon Medical Is Maintained at Speculative Buy by Benchmark
Express News | Benchmark Maintains Speculative Buy on Tenon Medical, Lowers Price Target to $3
Tenon Medical Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/15/2024 282.65% Benchmark $5 → $3 Maintains Speculative Buy 03/10/2023 665.31% Benchmark → $6 Reiterate
Express News | Tenon Medical Inc : Benchmark Cuts Target Price to $3 From $5
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersARCA biopharma (NASDAQ:ABIO) stock moved upwards by 124.6% to $3.84 during Wednesday's pre-market session. The market value of their outstanding shares is at $55.6 million. Kintara Therapeutics
Tenon Medical, Inc. Enhances Board With New Appointment
No Data